Free Trial
OTCMKTS:INBP

Integrated BioPharma (INBP) Stock Price, News & Analysis

Integrated BioPharma logo
$0.18 0.00 (-0.05%)
As of 10/13/2026 03:06 PM Eastern

About Integrated BioPharma Stock (OTCMKTS:INBP)

Advanced

Key Stats

Today's Range
$0.18
▼
$0.18
50-Day Range
$0.15
▼
$0.19
52-Week Range
$0.14
▼
$0.42
Volume
125 shs
Average Volume
20,129 shs
Market Capitalization
$5.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Integrated BioPharma, Inc. (OTCMKTS:INBP) is a healthcare products company engaged in the manufacture and distribution of vitamins, nutritional supplements, herbal products, and pharmaceutical products. Its activities are focused on products intended to support general health and wellness.

The company has historically served the U.S. market through a combination of proprietary products, contract manufacturing, and wholesale distribution activities. Its manufacturing capabilities have included a range of product formats, such as capsules, tablets, softgels, liquids, powders, creams, and lotions, depending on customer and product requirements.

Integrated BioPharma’s operations have included the development, production, and distribution of health-related consumer products for its own brands and other businesses. Publicly available information about its current leadership structure, product portfolio, and geographic reach is limited.

AI Generated. May Contain Errors.

Receive INBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INBP Stock News Headlines

Elon's next millionaires start October 24?
SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into millionaires. One welder's $10,000 stock package made him a millionaire on IPO day. Former Wall Street CEO Dylan Jovine says Elon Musk's next venture could outsize everything he's built before. It runs on an obscure AI firm Musk has relied on since 2012, supplying crucial technology to Tesla, Starlink and SpaceX.tc pixel
Integrated BioPharma Holds 2025 Annual Stockholder Meeting
INBP Integrated BioPharma, Inc.
Integrated Biopharma Inc (INBP)
See More Headlines

INBP Stock Analysis - Frequently Asked Questions

Integrated BioPharma's stock was trading at $0.3550 on January 1st, 2026. Since then, INBP stock has decreased by 48.6% and is now trading at $0.1824.

Integrated BioPharma Inc. (OTCMKTS:INBP) announced its earnings results on Friday, September, 25th. The company reported ($0.04) EPS for the quarter. The company had revenue of $9.80 million for the quarter. Integrated BioPharma had a negative trailing twelve-month return on equity of 14.78% and a negative net margin of 6.48%.

Shares of INBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
9/25/2026
Today
10/13/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:INBP
CIK
1016504
Employees
150
Year Founded
1995

Profitability

EPS (Trailing Twelve Months)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.84 million
Net Margins
-6.48%
Pretax Margin
-5.84%
Return on Equity
-14.78%
Return on Assets
-11.24%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.00
Quick Ratio
1.42

Sales & Book Value

Annual Sales
$43.87 million
Price / Sales
0.13
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.57 per share
Price / Book
0.32

Miscellaneous

Outstanding Shares
30,980,000
Free Float
10,098,000
Market Cap
$5.65 million
Optionable
Not Optionable
Beta
0.50

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (OTCMKTS:INBP) was last updated on 10/13/2026 by MarketBeat.com Staff.
From Our Partners